These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
565 related articles for article (PubMed ID: 17460565)
1. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity. Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565 [TBL] [Abstract][Full Text] [Related]
2. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts. Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590 [TBL] [Abstract][Full Text] [Related]
3. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection. Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ Front Immunol; 2018; 9():3039. PubMed ID: 30740108 [TBL] [Abstract][Full Text] [Related]
4. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596 [TBL] [Abstract][Full Text] [Related]
5. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells. Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993 [TBL] [Abstract][Full Text] [Related]
6. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities. Youssef AR; Otley C; Mathieson PW; Smith RM Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743 [TBL] [Abstract][Full Text] [Related]
7. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571 [TBL] [Abstract][Full Text] [Related]
8. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777 [TBL] [Abstract][Full Text] [Related]
9. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells. Tanaka K; Sonoda K; Streilein JW Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532 [TBL] [Abstract][Full Text] [Related]
10. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody. Morton AL; Bell EB; Bolton EM; Marshall HE; Roadknight C; McDonagh M; Bradley JA Eur J Immunol; 1993 Sep; 23(9):2078-84. PubMed ID: 8103742 [TBL] [Abstract][Full Text] [Related]
11. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition. Sano Y; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658 [TBL] [Abstract][Full Text] [Related]
12. CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway. Skaro AI; Liwski RS; Zhou J; Vessie EL; Lee TD; Hirsch GM Cardiovasc Res; 2005 Jan; 65(1):283-91. PubMed ID: 15621057 [TBL] [Abstract][Full Text] [Related]
13. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y; Tang XD; Zhou PJ Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744 [TBL] [Abstract][Full Text] [Related]
14. Rejection of cardiac xenografts by CD4+ or CD8+ T cells. Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Anrather J; Bach FH J Immunol; 1999 Jan; 162(2):1206-14. PubMed ID: 9916754 [TBL] [Abstract][Full Text] [Related]
15. Allograft rejection in athymic nude rats by transferred T cell subsets. II. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to an isolated MHC class I disparity. Bell EB; Rejali D; Whitby EH; Sparshott SM; Yang CP Transplantation; 1990 Oct; 50(4):690-6. PubMed ID: 1977220 [TBL] [Abstract][Full Text] [Related]
16. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564 [TBL] [Abstract][Full Text] [Related]
17. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways. Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307 [TBL] [Abstract][Full Text] [Related]
18. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells. Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913 [TBL] [Abstract][Full Text] [Related]
19. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production. Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360 [TBL] [Abstract][Full Text] [Related]
20. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Yamada J; Kurimoto I; Streilein JW Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]